Case report: sub-clinical extramedullary B-ALL in the setting of relapse following targeted therapy.
Johns C, Erickson C, Jacobs A, Moon J, Baggott C, Dagher R, Nadel H, Balagtas J, Aftandilian C, Ramakrishna S, Lacayo N, Davis KL, Stieglitz E, Schultz L.
Johns C, et al.
Front Immunol. 2024 Sep 25;15:1423487. doi: 10.3389/fimmu.2024.1423487. eCollection 2024.
Front Immunol. 2024.
PMID: 39386214
Free PMC article.